Product Images Levetiracetam Extended Release

This appears to be a table showing the percentage of patients and results from a clinical trial for the use of Immediate-release Levetiracetam Tablets in dosages of 1000mg/day and 3000mg/day compared to a placebo. It shows that the 3000mg/day dosage had a statistically significant result compared to the placebo group, while the 1000mg/day dosage did not.*

The text is a combination of percentages and data related to a medical study with a placebo group and two other groups receiving different dosages of immediate-release Levetiracetam Tablets. It mentions a statistically significant result, but there is not enough context to understand the nature of the study or the results.*

The text represents data from a clinical trial comparing the effectiveness of immediate-release Levetiracetam Tablets at 3000 mg/day versus a placebo. The percentages likely represent the proportion of participants who experienced a certain outcome or improvement, and there is a mention of statistical significance between the Levetiracetam group and the placebo group. However, without further context or details, it is difficult to provide a specific and useful description of the data presented.*

NDC 75634-245-60 is a prescription medication called Levetiracetam. It is available in the form of 60 extended-release tablets that should be stored at a temperature of 25°C (77°F). These tablets contain 500 mg of Levetiracetam per tablet and are meant to be taken once daily. The medication should be dispensed with a child-resistant closure and the accompanying medication guide should be given to the patient by the pharmacist. The dosage recommendations can be found in the package insert. This medication is manufactured by Nivagen Pharmaceuticals, Inc. located in Sacramento, CA.*

Levetiracetam is a medication that comes in the form of extended-release tablets that are taken once daily. Each extended-release tablet contains 750 mg of levetiracetam. The usual dosage can be found in the package insert which should be given to the patient along with the medication guide. The tablets should be dispensed in a tight, light-resistant container with a child-resistant closure. The medication should be stored between 15-30°C (58-86°F). It is important to keep the medication out of reach of children. This medication is manufactured for Nivagen Pharmaceuticals, Inc. and any queries can be directed to their toll-free number.*